Advertisement

Nociceptin/Orphanin FQ Modulates Neurotransmitter Release in the Substantia Nigra: Biochemical and Behavioural Outcome

  • Matteo Marti
  • Massimiliano Manzalini
  • Clementina Bianchi
  • Christian Heidbreder
  • Michele Morari
  • Francesco Crespi
Conference paper
Part of the Advances in Behavioral Biology book series (ABBI, volume 56)

Keywords

Substantia Nigra Differential Pulse Voltammetry Rostral Ventromedial Medulla Intranigral Injection Dorsal Raphe Nucleus Neurone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

6. References

  1. Anton, B., Fein, J., To, T., Li, X., Silberstein, L., and Evans, C.J., 1996, Immunohistochemical localization of ORL-1 in the central nervous system of the rat, J. Comp. Neurol. 367:1–23.CrossRefGoogle Scholar
  2. Albin, R.A., Young, A.B., and Penney, B., 1989, The functional anatomy of the basal ganglia disorders, Trends Neurosci. 12:366–375.PubMedCrossRefGoogle Scholar
  3. Alexander, G.E., and Crutcher, M.D., 1990, Functional architecture of basal ganglia circuits: neural substrates of parallel processing, Trends Neurosci. 13:266–271.PubMedCrossRefGoogle Scholar
  4. Bata-Garcia, J.L., H-Lopez, F.J., A-Cervera, F.J., A-Sandoval G and G-Alfaro JL., 2002, Circling behaviour induced by injection of serotonin reuptake inhibitors in the substantia nigra, Pharmacol. Biochem. Behavior 71:361–371.Google Scholar
  5. Bergquist, F., Shahabi, H.N., Nissbrandt, H., 2003, Somatodendritic dopamine release in rat substantia nigra influences motor performance on the accelerating rod, Brain Res 973:81–91.PubMedCrossRefGoogle Scholar
  6. Blakley, G.G., Pohorecky, L.A., Benjamin, D., 2004, Behavioral and endocrine changes following antisense oligonucleotide-induced reduction in the rat NOP receptor, Psychopharmacology 171:421–428.PubMedCrossRefGoogle Scholar
  7. Blandini, F., and Greenamiry, J.T., 1998, Prospects of glutamate antagonists in the therapy of Parkinson’s disease, Fundam. Clin. Pharmacol. 12:4–12.PubMedCrossRefGoogle Scholar
  8. Boom, A., Mollereau, C., Meunier, J.C., Vassart, G., Parmentier, M., Vanderhaeghen, J.J., Schiffmann, S.N., 1999, Distribution of the nociceptin and nocistatin precursor transcript in the mouse central nervous system, Neuroscience 91:991–1007.PubMedCrossRefGoogle Scholar
  9. Bunzow, J.R., Saez, C., Mortrud, M., Bouvier, C., Williams, J.T., Low, M., and Grandy, D.K., 1994, Molecolar cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS lett. 347:284–288.PubMedCrossRefGoogle Scholar
  10. Calò, G., Guerrini, R., Rizzi, A., Salvadori, S., Regoli, D., 2000, Pharmacology of nociceptin and its receptor: a novel therapeutic target, Br. J. Pharmacol. 129:1261–1283.PubMedCrossRefGoogle Scholar
  11. Calò, G., Rizzi, A., Rizzi, D., Bigoni, R., Guerrini, R., Marzola, G., Marti, M., McDonald, J., Morari, M., Lambert, D.G., Salvadori, S., Regoli, D., 2002, [Nphe1,Arg14,Lys15]Nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor, Br. J. Pharmacol. 136:303–311.PubMedCrossRefGoogle Scholar
  12. Candeletti, S., and Ferri, S., 2000, Effects of an antisense oligonucleotide to pronociceptin and long-term prevention of morphine actions by nociceptin, Peptides 21:1119–1124.PubMedCrossRefGoogle Scholar
  13. Carter, C.J., 1982, Topographical distribution of possible glutamatergic pathways from the prefrontal cortex to the striatum and substantia nigra of the rat. Neuropharmacol. 21:379–383.CrossRefGoogle Scholar
  14. Chu, X., Xu, N., Li, P., and Wang, J.Q., 1999, The nociceptin receptor-mediated inhibition of the rat rostral ventrolateral medulla neurons in vitro, Eur. J. Pharmacol. 364:49–53.PubMedCrossRefGoogle Scholar
  15. Cox, B.M., Chavkin, C., Christie, M.J., Civelli, O., Evans, C., Hamon, M.D., Hoellt, V., Kieffer, B., Kitchen, I., Mcknight, A.T., Meunier, J.C., Portoghese, P.S., 2000, Opioid Receptors. In: The IUPHAR Compendium of Receptor Characterization and Classification. (Girdlestone D ed): IUPHAR Media Ltd, London.Google Scholar
  16. Crespi, F., Martin, K.F., and Marsden, C.A., 1988, Measurement of extracellular basal levels of serotonin in vivo using nafion-coated carbon fibre electrodes combined with differential pulse voltammetry, Neuroscience. 27:885–896.PubMedCrossRefGoogle Scholar
  17. Darland, T., Heinricher, M.M., and Grandy, D.Y., 1998, Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more, Trends Neurosci., 21:215–221.PubMedCrossRefGoogle Scholar
  18. Devine, D.P., Taylor, L., Reinscheid, R.K., Monsma, F.J. Jr, Civelli, O., Akil, H., 1996a, Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ, Neurochem. Res. 21:1387–1396.PubMedGoogle Scholar
  19. Devine, D.P., Reinscheid, R.K., Monsma, F.J. Jr, Civelli, O., Akil, H., 1996b, The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion, Brain Res. 727:225–229.PubMedCrossRefGoogle Scholar
  20. Di Giannuario, A., Pieretti, S., Catalani, A., Loizzo, A., 1999, Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats, Neurosci. Lett. 272:183–186.PubMedCrossRefGoogle Scholar
  21. Di Giannuario, A., and Pieretti, S., 2000, Nociceptin differentially affects morphine-induced dopamine release from the nucleus accumbens and nucleus caudate in rats, Peptides 21:1125–1130.PubMedCrossRefGoogle Scholar
  22. Dray, A., Davies, J., and Oakley, N.R., Tongroach, P., Vellucci, S., 1978, The dorsal and medial raphe projections to the substantia nigra in the rat: electrophysiological, biochemical and behavioural observations, Brain Research 151:431–442.PubMedCrossRefGoogle Scholar
  23. Gavioli, E.C., Marzola, G., Guerrini, R., Bertorelli, R., Zucchini, S., De Lima, T.C., Rae, G.A., Salvadori, S., Regoli, D., Calò, G., 2003, Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressantlike effects: pharmacological and genetic evidences from the mouse forced swimming test, Eur. J. Neurosci. 17:1987–1990.PubMedCrossRefGoogle Scholar
  24. Guerrini, R., Calò, G., Bigoni, R., Rizzi, A., Varani, K., Toth, G., Gessi, S., Hashiba, E., Hashimoto, Y., Lambert, D.G., Borea, P.A., Tomatis, R., Salvadori, S., Regoli, D., 2000, Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor, J. Med. Chem. 43:2805–2813.PubMedCrossRefGoogle Scholar
  25. Higgins, G.A., Jordan, C.C., and Skingle, M., 1991, Evidence that the unilateral actvation of 5-HT1D receptors in the substantia nigra of the guinea-pig elicits contralateral rotation, Br. J. Pharmacol. 102:305–310.PubMedGoogle Scholar
  26. Higgins, G.A., Grottick, A.J., Ballard, T.M., Richards, J.G., Messer, J., Takeshima, H., Pauly-Evers, M., Jenck, F., Adam, G., and Wichmann, J., 2001, Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function, Neuropharmacology 41:97–107.PubMedCrossRefGoogle Scholar
  27. Hillegaart, V., Magnusson, O., and Ahlenius, S., 2000, A9 and A10 dopamine nuclei as a site of action for effects of 8-OH-DPAT on locomotion in the rat, Pharmacol. Biochem. Behav. 67:55–63.PubMedCrossRefGoogle Scholar
  28. Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharane, E.J., Saxena, P.R., and Humphrey, P.P.A., 1994, International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin), Pharmacol. Rev. 46:157–193.PubMedGoogle Scholar
  29. Imai, H., Steindler, D.A., and Kitai, S.T., 1986, The organization of divergent axonal projections from the midbrain raphe nuclei in the rat, J. Comp. Neurol. 15:363–80.CrossRefGoogle Scholar
  30. Jacobs, B.L., and Fornal, C.A., 1997, Serotonin and motor activity. Curr. Opin. Neurobiol. 7:820–825.PubMedCrossRefGoogle Scholar
  31. Janssen P.A.J., 1983, 5-HT2 receptor blockade to study serotonin-induced pathology. TIPS 198–206.Google Scholar
  32. Jenck, F., Wichmann, J., Dautzenberg, F.M., Moreau, J.L., Ouagazzal, A.M., Martin, J.R., Lundstrom, K., Cesura, A.M., Poli, S.M., Roever, S., Kolczewski, S., Adam, G., and Kilpatrick, G., 2000, A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat, Proc. Natl. Acad. Sci. USA. 97:4938–4943.PubMedCrossRefGoogle Scholar
  33. Koizumi, M., Midorikawa, N., Takeshima, H., and Murphy, N.P., 2004, Exogenous, but not endogenous nociceptin modulates mesolimbic dopamine release in mice, J. Neurochem. 89:257–263.PubMedCrossRefGoogle Scholar
  34. Kuzmin, A., Sandin, J., Terenius, L., and Ogren, S.O., 2004, Evidence in locomotion test for the functional heterogeneity of ORL-1 receptors, Br. J. Pharmacol. 141:132–140.PubMedCrossRefGoogle Scholar
  35. Lutfy, K., Do, T., and Maidment, N.T., 2001, Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats, Psychopharmacology (Berl) 154:1–7.PubMedCrossRefGoogle Scholar
  36. Maidment, N.T., Chen, Y., Tan, A.M., Murphy, N.P., and Leslie, F.M., 2002, Rat ventral midbrain dopamine neurons express the orphanin FQ/nociceptin receptor ORL-1, Neuroreport 13:1137–1140.PubMedCrossRefGoogle Scholar
  37. Marti, M., Guerrini, R., Beani, L., Bianchi, C., and Morari, M., 2002, Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat, Neuroscience 112:153–160.PubMedCrossRefGoogle Scholar
  38. Marti, M., Stocchi, S., Paganini, F., Mela, F., De Risi, C., Calò, G., Guerrini, R., Barnes, T.A., Lambert, D.G., Beani, L., Bianchi, C., and Morari, M., 2003, Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulatine 5-hidroxytryptamine and noradrenaline release in the rat neocortex, Br. J. Pharmacol 138:91–98.PubMedCrossRefGoogle Scholar
  39. Marti, M., Mela, F., Veronesi, C., Guerrini, R., Salvatori, S., Federici, M., Mercuri, N.B., Rizzi, A., Franchi, G., Beani, L., Bianchi, C., and Morari, M., 2004a, Blockade of nociceptin/orphanin FQ receptor signalling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behaviour, J. Neurosci. 24:6659–6666.PubMedCrossRefGoogle Scholar
  40. Marti, M., Mela, F., Trapella, C., Bianchi, C., and Morari, M., 2004b, Blockade of nociceptin/orphanin FQ transmission attenuates hypokinesia in hemiparkinsonian rats, Mov. Dis. 19(Suppl 9), P564.Google Scholar
  41. Marti, M., Mela, F., Guerrini, R., Calò, G., Bianchi, C., and Morari, M., 2004c, Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release, J. Neurochem. 91:1501–1504.PubMedCrossRefGoogle Scholar
  42. Mela, F., Marti, M., Ulazzi, L., Vaccai, E., Zucchini, S., Trapella, C., Salvatori, S., Beani, L., Bianchi, C., and Morari, M., 2004, Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex, Eur. J. Neurosci. 19:1–8.CrossRefGoogle Scholar
  43. Meunier, J.C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., Butour, J.L., Guillemot, J.C., Ferrara, P., Monsarrat, B., Mazarguil, H., Vassart, G., Parmentier, M., and Costentin, J., 1995, Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor, Nature 377:532–535.PubMedCrossRefGoogle Scholar
  44. Mogil, J.S., and Pasternak, G.W., 2001, The molecular and behavioral pharmacology of the orphanin FQ/Nociceptin peptide and receptor family, Pharmacol. Rev. 53:381–415.PubMedGoogle Scholar
  45. Murphy, N.P., and Maidment, N.T., 1999, Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis, J. Neurochem. 73:179–186.PubMedCrossRefGoogle Scholar
  46. Murphy, N.P., Lam, H.A., Chen, Z., Pintar, J.E., and Maidment, N.T., 2002, Heroin-induced locomotion and mesolimbic dopamine release is unchanged in mice lacking the ORL.1 receptor gene, Brain Res. 953:276–280.PubMedCrossRefGoogle Scholar
  47. Narayanan, K., Lam, H., Carroll, I., and Lutfy, K., 2004, OrphaninFQ/nociceptin suppresses motor activity through an action along the mesoaccumbens axis in rats, Rev. Psychiatr. 29:116–123.Google Scholar
  48. Neal C.R. JR, Mansour, A., Reinscheid, R., Nothacker, H.P., Civelli, O., Akil, H., and Watson, S.J., JR., 1999, Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with 125I-[14Tyr]-orphanin FQ binding, J. Comp. Neurol. 412:563–605.PubMedCrossRefGoogle Scholar
  49. Nishi, M., Houtani, T., Noda, Y., Mamiya, T., Sato, K., Doi, T., Kuno, J., Takeshima, H., Nukada, T., Nabeshima, T., Yamashita, T., Noda, T., and Sugimoto, T., 1997, Unrestrained nociceptive response and dysregulation of hearing ability in mice lacking the nociceptin/orphaninFQ receptor, EMBO J. 16:1858–1864.PubMedCrossRefGoogle Scholar
  50. Noble, F., and Roques, B.P., 1997, Association of aminopeptidase N and endopeptidase 24.15 inhibitors potentiate behavioral effects mediated by nociceptin/orphanin FQ in mice, FEBS Lett. 401:227–229.PubMedCrossRefGoogle Scholar
  51. Noda, Y., Mamiya, T., Nabeshima, T., Nishi, M., Higashioka, M., and Takeshima, H., 1998, Loss of antinociception induced by naloxone benzoylhydrazone in nociceptin receptor-knockout mice, J. Biol. Chem. 273:18047–18051.PubMedCrossRefGoogle Scholar
  52. Norton, C.S., Neal, C.R., Kumar, S., Akil, H., and Watson, S.J., 2002, Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems, J. Comp. Neurol. 444:358–368.PubMedCrossRefGoogle Scholar
  53. Oberlander, C., Hunt, P.F., Dumont, C., and Boissier, J.R., 1981, Dopamine independent rotational response to unilateral intranigral injection of serotonin, Life Sci. 28:2595–2601.PubMedCrossRefGoogle Scholar
  54. Okabe, C., and Murphy, N.P., 2004, Short-term of the nociceptin receptor antagonist Compound B on the development of methamphetamine sensitization in mice: a behavioural and c-fos expression mapping study, Brain Res. 1017:1:12.CrossRefGoogle Scholar
  55. Paxinos, G., and Watson, C., 1982, The Rat Brain in Stereotaxic Coordinates. Academic, Sydney.Google Scholar
  56. Reinscheid, R.K., Nothacker, H.P., Bourson, A., Ardati, A., Henningsen, R.A., Bunzow, J.R., Grandy, D.K., Langen, H., Monsma, F.J. Jr, and Civelli, O., 1995, Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor, Science 270:792–794.PubMedGoogle Scholar
  57. Rinvik, E., and Ottersen, O.P., 1993, Terminals of subthalamonigral fibres are enriched with glutamate-like immunoreactivity: an electron microscopy, immunogold analysis in the cat, J. Chem. Neuroanat. 6:19–30.PubMedCrossRefGoogle Scholar
  58. Rizzi, A., Bigoni, R., Marzola, G., Guerrini, R., Salvadori, S., Regoli, D., and Calo’, G., 2001, Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice, Naunyn Schmiedebergs Arch. Pharmacol. 363:161–165.PubMedCrossRefGoogle Scholar
  59. Robledo, P., and Feger, J., 1990, Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiologicol data, Brain Res. 518:47–54.PubMedCrossRefGoogle Scholar
  60. Sandin, J., Georgieva, J., Schott, P.A., Ogren, S.O., and Terenius, L., 1997, Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats, Eur. J. Neurosci. 9:194–197.PubMedCrossRefGoogle Scholar
  61. Sbrenna, S., Marti, M., Morari, M., Calo’, G., Guerrini, R., Beani, L., and Bianchi, C., 2000, Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin, Br. J. Pharmacol. 130:425–433.PubMedCrossRefGoogle Scholar
  62. Schlicker, E., and Morari, M., 2000, Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system, Peptides 21:1023–1029.PubMedCrossRefGoogle Scholar
  63. Slowe, S.J., Clarke, S., Lena, I., Goody, R.J., Lattanzi, R., Negri, L., Simonin, F., Matthes, H.W., Filliol, D., Kieffer, B.L., and Kitchen, I., 2001, Autoradiographic mapping of the opioid receptor-like 1 (ORL1) receptor in the brains of mu-, delta-or kappa-opioid receptor knockout mice, Neuroscience 106:469–480.PubMedCrossRefGoogle Scholar
  64. Starr, M.S., 1995, Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson’s disease, Synapse 19:264–293.PubMedCrossRefGoogle Scholar
  65. Stratford, T.R., Holahan, M.R., and Kelley, A.E., 1997, Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake, Neuroreport 8:423–426.PubMedGoogle Scholar
  66. Tokuno, H., Morizumi, T., Kumo, M., and Nakamura, Y., 1988, A morphological evidence for monosynaptic projection from the nucleus peduncolopontinus pars compacta (TPC) to nigrostriatal projection neurons, Neurosci. Lett., 85:1–4.PubMedCrossRefGoogle Scholar
  67. Ueda, H., Inoue, M., Takeshima, H., and Iwasawa, Y., 2000, Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence, J. Neurosci. 20:7640–7647.PubMedGoogle Scholar
  68. Vaughan, C.W., and Christie, M.J., 1996, Increase by the ORL1 receptor (opioid receptor-like1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones, Br. J. Pharmacol. 117:1609–1611.PubMedGoogle Scholar
  69. Vaughan, C.W., Connor, M., Jennings, E.A., Marinelli, S., Allen, R.G., and Christie, M.J., 2001, Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro, J. Physiol. 534:849–859.PubMedCrossRefGoogle Scholar
  70. Walker, J.R., Spina, M., Terenius, L., and Koob, G.F., 1998, Nociceptin fails to affect heroin self-administration in the rat, Neuroreport 9:2243–2247.PubMedGoogle Scholar
  71. Zheng, F., Grandy, D.K., and Johnson, S.W., 2002, Actions of orphanin FQ/nociceptin on rat ventral tegmental area neurons in vitro, Br. J. Pharmacol. 136:1065–1071.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • Matteo Marti
    • 1
  • Massimiliano Manzalini
    • 1
  • Clementina Bianchi
    • 1
  • Christian Heidbreder
    • 2
  • Michele Morari
    • 1
  • Francesco Crespi
    • 2
  1. 1.Department of Experimental and Clinical Medicine, Section of Pharmacology, and Neuroscience CenterUniversity of FerraraItaly
  2. 2.Department of Biology, Center of Excellence for Drug Discovery in PsychiatryGlaxoSmithKline PharmaceuticalsVeronaItaly

Personalised recommendations